Clavmoxwel-156.25

Akums Drugs & Pharmaceuticals Ltd. (Plant I-Solid Oral Dosage Facility)🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 1b0c39003c3d5af2
Company: Akums Drugs & Pharmaceuticals Ltd. (Plant I-Solid Oral Dosage Facility)
Type: Standard

Approval Id: 1b0c39003c3d5af2
Drug Approval Philippines Name: Clavmoxwel-156.25
Product Name: Clavmoxwel-156.25
Registration Number: DRP-4231
Brand Name: Clavmoxwel-156.25
Generic Name: Co-Amoxiclav
Dosage Form: Powder for Suspension
Dosage Strength: 156.25 mg per 5 mL
Manufacturer: Akums Drugs & Pharmaceuticals Ltd. (Plant I-Solid Oral Dosage Facility)
Importer: Ambica International Corporation
Distributor: Diafarm, Inc
Issuance Date: 25 August 2022
Expiry Date: 14 February 2028
Pharmacologic Category: Antibacterial (Penicillin/Beta-Lactamase Inhibitor)
Classification: Prescription Drug (Rx)

Approved

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

1b0c39003c3d5af2

Type

Standard